ZMUni Compliance Centre

  On June 26, China's National Medical Products Administration (NMPA) issued the Provisions for Management of New Cosmetic Ingredient Registration and Notification Dossiers (hereinafter the "New Provisions"), effective July 15, replacing the 2021 version. The new rules consist of 15 articles and aim to clarify regulatory boundaries, streamline administrative requirements, and encourage innovation by reducing compliance burdens for new cosmetic ingredient development.   The revised framework separates administrative and technical requirements, removing detailed technical content such as development reports, manufacturing processes, and safety assessment materials from the regulation and instead linking them to technical guidance documents. It also introduces updated

    On June 22, 2026, China's General Administration of Customs (GACC) released its list of non-compliant imported food products for May 2026. A total of 706 batches from 43 countries and regions were denied entry, representing a month-on-month increase of approximately 52% (up 243 batches from 463 in March 2026) and a year-on-year increase of about 65% (up 278 batches from 428 in the same period last year).   The rejected shipments spanned a wide array of categories, including dairy, vegetable oils, alcoholic beverages, frozen livestock and seafood, snacks, and beverages. Geographically, Ecuador saw the most significant spike, accounting

From June 15 to June 23, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA). The technical requirements have not been disclosed yet.     Polymers   Notification No. 20260104  Hydrogenated Soy Polyglycerides is the product obtained through catalytic metathesis of Glycine Soja (Soybean) Oil, followed by hydrogenation. According to PCPC, its functions include Skin-Conditioning Agent (Occlusive) and Viscosity Increasing Agent (Nonaqueous). This notification marks the first NCI submission from a Singapore-based company under China's NCI framework.   Notification No. 20260105 and Notification No. 20260106 In this issue, Intercos S.p.A. notified two NCIs, both

"Plant-derived exosomes" have become a focal point in global cosmetic ingredient innovation due to their natural origin, biocompatibility, and targeted delivery capabilities. However, as an emerging bio-based ingredient, they still face significant regulatory hurdles in China—including scientific nomenclature, classification as "New Cosmetic Ingredients" (NCI), and the design of appropriate notification and registration pathways.   This article provides a structured overview of how these materials are currently understood under China’s regulatory framework, with reference to international nomenclature practices and key compliance considerations.     01. Nomenclature: The "Vesicle" vs. "Exosome" Distinction   Under the International Nomenclature of Cosmetic Ingredients (INCI) framework,

   On June 15, 2026, China's National Medical Products Administration(NMPA) released two draft mandatory national standards for public consultation: Evaluation Criteria and Management Principles for Cosmetic Cheilitis and Evaluation Criteria and Management Principles for Cosmetic Contact Urticaria. The consultation period runs from June 15 to August 15, 2026.   Since the implementation of the Cosmetic Supervision and Administration Regulation(CSAR) in 2021, China has established a cosmetic adverse reaction monitoring system. The Measures for the Management of Cosmetic Adverse Reaction Monitoring further introduced the principle of “suspected cases should be reported.” However, unified national criteria for determining specific types of adverse

  From June 8 to June 12, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).     Peptides   Notification No. 20260097 - sr-(Tripeptide-133 sh-Polypeptide-2 Hexapeptide-40)   According to the publicly available patent filed by the notifier (CN120918980A), sr-(Tripeptide-133 sh-Polypeptide-2 Hexapeptide-40) demonstrates strong antioxidant activity and can act synergistically with other active ingredients. It enables the development of a new, high-performance active ingredient system applicable in both skincare and hair care products, enhancing antioxidant and repair-related efficacy.     Notification No. 20260100   Hexapeptide-125 (translated from Chinese name, official INCI name currently

ZMUni Compliance Center has recently supported two overseas food manufacturers in successfully completing registration with China’s General Administration of Customs (GACC) as overseas manufacturers of imported food, enabling compliant access to the Chinese market.      Case 1 | LLC First Alive Collagen & Hydrolyzed Collagen Products (Russia)      ZMUni supported LLC "First Alive Collagen" in completing its GACC registration as an overseas food production enterprise. With the registration approved, the company is now eligible to export hydrolyzed collagen products to China, enabling compliant import and customs clearance.   First Alive Collagen is a Russian biotechnology company focused on collagen-based

  From May 26 to June 3, 2026, 6 new cosmetic ingredients (NCIs) have completed notifications with China’s National Medical Products Administration (NMPA).     Rosa Alba Flower Water   Rosa alba (White Rose) is a classic botanical prized for centuries in both Eastern and Western cultures. Renowned for its delicate fragrance and pure white blossoms, it has traditionally been used in soothing skincare and aromatic applications, combining natural beauty with botanical care.     Pyropia Haitanensis Extract   Pyropia haitanensis is an edible red algae mainly found along the southeastern coast of China, particularly in Zhejiang and Fujian provinces.